Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Ana C B TerzianLaboratório de Imunologia Celular e Molecular, Instituto René Rachou, Fundação Osvaldo Cruz, Belo Horizonte 30190-009, MG, Brazil.ORCID 0000-0001-7157-7825
Sasha R AzarCenter for Tissue Engineering, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030-2703, USA.ORCID 0000-0002-9182-216X
Cassia F EstofoleteLaboratório de Pesquisas em Virologia, Departamento de Doenças Dermatológicas, Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, SP, Brazil.
Mauricio L NogueiraLaboratório de Pesquisas em Virologia, Departamento de Doenças Dermatológicas, Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, SP, Brazil.ORCID 0000-0003-1102-2419
Nikos VasilakisDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA.ORCID 0000-0002-0708-3289
Funding
Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Kathryn Alyce Hanley, MAURICIO Lacerda NOGUEIRA · 2020 to 2026
$9.8M
Mechanisms and Public Health Impact of Sylvatic Dengue Virus Emergence in BorneoU01AI115577 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI VASILAKIS, NIKOS · 2016 to 2019
$2.4M
Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/03645-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/09229-0Institutos Nacionais de Ciência e Tecnologia 405786/2022-0National Council for Scientific and Technological Development 404096/2020-4NIAID NIH HHS U01 AI151807NIH HHS U01AI115577NIH HHS U01AI151807The Rede Corona-Ômica BR MCTI/FINEP FINEP 01.20.0029.000462/20
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Differential Neutralization Profiles of 17DD Vaccinated Population to 17D-204 and 17DD Vaccine Strains. · full record | OpenQuestion